Prothena Corporation PLC
NASDAQ:PRTA
Prothena Corporation PLC
Income from Continuing Operations
Prothena Corporation PLC
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prothena Corporation PLC
NASDAQ:PRTA
|
Income from Continuing Operations
-$172.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-28%
|
|
Alkermes Plc
NASDAQ:ALKS
|
Income from Continuing Operations
$600m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Income from Continuing Operations
-$52.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Income from Continuing Operations
-$207.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prothena Corporation PLC's Income from Continuing Operations?
Income from Continuing Operations
-172.4m
USD
Based on the financial report for Mar 31, 2024, Prothena Corporation PLC's Income from Continuing Operations amounts to -172.4m USD.
What is Prothena Corporation PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-28%
Over the last year, the Income from Continuing Operations growth was -35%. The average annual Income from Continuing Operations growth rates for Prothena Corporation PLC have been -12% over the past three years , -6% over the past five years , and -28% over the past ten years .